427 material Form 8-K filings that 376 companies we cover made with the SEC in September 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Sotera Health entered Amendment No. 6 to its First Lien Credit Agreement on September 17, 2025, which reprices its term loans. The Repriced Term Loans total $1,423,029,875 after the company used $75,000,000 of available cash to repay part of its term loan facility, and they mature on May 30, 2031. The amendment lowers the interest rate spread by 0.50%, which matters to shareholders because it reduces the company's borrowing cost on this debt.
Repriced Term Loans total $1,423,029,875 to Sotera Health Holdings, LLC, after a $75,000,000 cash repayment
Interest margin set at Adjusted Term SOFR plus 2.50%, reflecting a 0.50% reduction from this amendment and a previously triggered 0.25% step-down
Loans amortize at 1.00% per year, mature May 30, 2031, and carry a 1.00% soft call premium for repricings within six months
Amendment filed as Exhibit 10.1; JPMorgan Chase Bank, N.A. is first lien Administrative Agent
FedEx reported fiscal first-quarter results for the period ended August 31, 2025, with revenue of $22.2 billion, up 3% from a year earlier, and GAAP diluted EPS of $3.46, up from $3.21. The company also initiated full-year fiscal 2026 EPS guidance of $14.20 to $16.00 before pension mark-to-market adjustments, and reaffirmed its cost-reduction and capital spending targets. Shareholders are affected by the $0.5 billion of share repurchases in the quarter and the planned FedEx Freight spin-off by June 2026.
Revenue was $22.2 billion versus $21.6 billion a year earlier; GAAP operating income was $1.19 billion versus $1.08 billion.
GAAP diluted EPS was $3.46 versus $3.21; adjusted diluted EPS was $3.83 versus $3.60.
Fiscal 2026 EPS guidance is $14.20 to $16.00 before MTM pension adjustments, or $17.20 to $19.00 after excluding certain costs; revenue growth is forecast at 4% to 6%.
$0.5 billion of shares were repurchased in the quarter, with $1.6 billion remaining under the 2024 authorization as of August 31, 2025.
Darden Restaurants reported first-quarter fiscal 2026 results for the period ended August 24, 2025, with total sales up 10.4% to $3.0 billion and reported diluted earnings per share from continuing operations of $2.19, compared with $1.74 a year earlier. The company also updated its fiscal 2026 outlook, now calling for adjusted diluted EPS from continuing operations of $10.50 to $10.70, and declared a $1.50 quarterly dividend.
Total sales rose 10.4% to $3,044.7 million; blended same-restaurant sales increased 4.7%
Adjusted diluted EPS from continuing operations was $1.97, up 12.6% from $1.75; reported EPS was $2.19
Fiscal 2026 adjusted diluted EPS outlook is $10.50 to $10.70, including about $0.20 from a 53rd week
Quarterly dividend of $1.50 per share is payable November 3, 2025; company repurchased $183 million of stock in the quarter
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.